Valencia, Spain, to host 2 major bone meetings in March 2011

August 10, 2010

Two bone-related meetings, jointly organized by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and International Osteoporosis Foundation (IOF) will take place in Valencia, Spain in March 2011.

The EUROPEAN CONGRESS ON OSTEOPOROSIS & OSTEOARTHRITIS from March 23-26, 2011 (http://www.ecceo11-iof.org ) chaired by Jean-Yves Reginster (ESCEO President) and John A. Kanis (IOF President) will be the largest educational event and most important clinical research forum for osteoporosis and osteoarthritis in Europe. Participants are eligible for CME credits.

The exciting scientific programme features:

->Plenary lectures by leading speakers: ->Meet the Professor Sessions to encourage discussion and debate: In addition there will be special sessions and symposia, honorary and educational lectures, oral presentations, posters, six informative Satellite Symposia, award presentations and a large industry exhibition.

->ABSTRACT DEADLINE January 14, 2011:

Abstracts will be published in the field's leading journal Osteoporosis International. Online abstract submission will be available at www.ecceo11-iof.org

IOF and ESCEO are also pleased to announce the 1st IOF-ESCEO PRE-CLINICAL SYMPOSIUM on March 22-23, 2011. Chaired by Gerard Karsenty, this symposium will provide an important new platform for basic and translational research. Young scientists will be invited to showcase their work through dedicated oral presentation sessions, with numerous awards offered for top ranking abstracts. Preliminary programme available on www.ecceo11-iof.org

We hope to welcome you to the Valencia! Located on the shores of the Mediterranean Sea, Valencia is Spain's third largest city and known for its wonderful architecture, great seafood, and world famous 'Las Fallas' festival (to take place just prior to the Congress from March 15-19, 2011).

*preliminary programme, subject to change

KEY DATES:



Abtract Submission: January 14, 2011
Early registration: December 10, 2010
-end-
ABOUT IOF

The International Osteoporosis Foundation (IOF) is a non-profit, nongovernmental organization dedicated to the worldwide fight against osteoporosis, the disease known as "the silent epidemic". IOF's members - committees of scientific researchers, patient, medical and research societies and industry representatives from around the world - share a common vision of a world without osteoporotic fractures. IOF now represents 196 societies in 93 locations around the world. http://www.iofbonehealth.org

ABOUT ESCEO

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.